$38.7 Billion is the total value of ADAGE CAPITAL PARTNERS GP, L.L.C.'s 688 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY INC | $375,320,000 | -36.6% | 5,686,668 | 0.0% | 0.97% | -40.0% | |
| AMAG | AMAG PHARMACEUTICALS INC | $78,665,000 | +7.1% | 3,796,592 | 0.0% | 0.20% | +1.0% | |
| HUBA | HUBBELL INCcl a | $72,947,000 | +12.2% | 584,532 | 0.0% | 0.19% | +6.2% | |
| COFWS | CAPITAL ONE FINL CORP*w exp 11/14/201 | $70,731,000 | +14.2% | 1,752,500 | 0.0% | 0.18% | +8.3% | |
| UNITED RENTALS INCnote 4.000%11/1 | $70,509,000 | +10.4% | 7,500,000 | 0.0% | 0.18% | +4.6% | ||
| EE | EL PASO ELEC CO | $56,302,000 | +12.5% | 1,400,209 | 0.0% | 0.14% | +5.8% | |
| LBTYK | LIBERTY GLOBAL PLC | $35,858,000 | +3.9% | 847,500 | 0.0% | 0.09% | -1.1% | |
| EQUINIX INCnote 4.750% 6/1 | $34,020,000 | +13.1% | 13,328,000 | 0.0% | 0.09% | +7.3% | ||
| MYLAN INCnote 3.750% 9/1 | $29,077,000 | +5.5% | 7,500,000 | 0.0% | 0.08% | 0.0% | ||
| IDIX | IDENIX PHARMACEUTICALS INC | $28,489,000 | +299.7% | 1,182,107 | 0.0% | 0.07% | +289.5% | |
| HIGWS | HARTFORD FINL SVCS GROUP INC*w exp 06/26/201 | $26,540,000 | +2.1% | 975,000 | 0.0% | 0.07% | -2.8% | |
| ALRPRB | ALERE INCperp pfd conv se | $23,759,000 | +9.7% | 74,743 | 0.0% | 0.06% | +3.4% | |
| PSUNQ | PACIFIC SUNWEAR CALIF INC | $23,681,000 | -19.9% | 9,950,053 | 0.0% | 0.06% | -24.7% | |
| LBTYA | LIBERTY GLOBAL PLC | $22,884,000 | +6.3% | 517,500 | 0.0% | 0.06% | 0.0% | |
| CSU | CAPITAL SR LIVING CORP | $22,355,000 | -8.3% | 937,700 | 0.0% | 0.06% | -13.4% | |
| CPK | CHESAPEAKE UTILS CORP | $21,399,000 | +12.9% | 300,000 | 0.0% | 0.06% | +5.8% | |
| CPRT | COPART INC | $20,981,000 | -1.2% | 583,444 | 0.0% | 0.05% | -6.9% | |
| NOVELLUS SYS INCnote 2.625% 5/1 | $20,238,000 | +18.6% | 10,000,000 | 0.0% | 0.05% | +10.6% | ||
| BG | BUNGE LIMITED | $19,717,000 | -4.9% | 260,671 | 0.0% | 0.05% | -10.5% | |
| PETX | ARATANA THERAPEUTICS INC | $19,903,000 | -15.9% | 1,275,000 | 0.0% | 0.05% | -21.5% | |
| LNCWS | LINCOLN NATL CORP IND*w exp 07/10/201 | $18,420,000 | +2.4% | 433,400 | 0.0% | 0.05% | -2.0% | |
| ODP | OFFICE DEPOT INC | $14,236,000 | +37.8% | 2,501,877 | 0.0% | 0.04% | +32.1% | |
| SWY | SAFEWAY INC | $12,893,000 | -7.0% | 375,440 | 0.0% | 0.03% | -13.2% | |
| CEMEX SAB DE CVnote 3.250% 3/1 | $11,615,000 | +5.7% | 8,000,000 | 0.0% | 0.03% | 0.0% | ||
| ATR | APTARGROUP INC | $11,346,000 | +1.4% | 169,313 | 0.0% | 0.03% | -6.5% | |
| MICROCHIP TECHNOLOGY INCsdcv 2.125%12/1 | $9,553,000 | +3.0% | 5,000,000 | 0.0% | 0.02% | 0.0% | ||
| MNDL | MANDALAY DIGITAL GROUP INC | $9,535,000 | 0.0% | 2,413,891 | 0.0% | 0.02% | -3.8% | |
| CRME | CARDIOME PHARMA CORP | $8,917,000 | -0.6% | 1,132,260 | 0.0% | 0.02% | -4.2% | |
| GOLD | BARRICK GOLD CORP | $7,328,000 | +2.8% | 400,000 | 0.0% | 0.02% | 0.0% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $5,152,000 | -24.9% | 510,148 | 0.0% | 0.01% | -31.6% | |
| CNAT | CONATUS PHARMACEUTICALS INC | $5,011,000 | +12.0% | 550,000 | 0.0% | 0.01% | +8.3% | |
| ICEL | CELLULAR DYNAMICS INTL INC | $4,983,000 | -2.4% | 342,000 | 0.0% | 0.01% | -7.1% | |
| TRVN | TREVENA INC | $4,520,000 | -28.1% | 800,000 | 0.0% | 0.01% | -29.4% | |
| ELGX | ENDOLOGIX INC | $4,454,000 | +18.2% | 292,837 | 0.0% | 0.01% | +20.0% | |
| HMHC | HOUGHTON MIFFLIN HARCOURT CO | $4,311,000 | -5.7% | 225,000 | 0.0% | 0.01% | -8.3% | |
| BLDR | BUILDERS FIRSTSOURCE INC | $4,291,000 | -17.8% | 573,634 | 0.0% | 0.01% | -21.4% | |
| DSX | DIANA SHIPPING INC | $4,356,000 | -9.2% | 400,000 | 0.0% | 0.01% | -15.4% | |
| E | ENI S P Asponsored adr | $3,294,000 | +9.4% | 60,000 | 0.0% | 0.01% | +12.5% | |
| AMRN | AMARIN CORP PLCspons adr new | $3,520,000 | -2.8% | 2,000,000 | 0.0% | 0.01% | -10.0% | |
| ONTY | ONCOTHYREON INC | $3,078,000 | +8.3% | 950,000 | 0.0% | 0.01% | 0.0% | |
| THR | THERMON GROUP HLDGS INC | $2,857,000 | +13.6% | 108,558 | 0.0% | 0.01% | 0.0% | |
| SB | SAFE BULKERS INC | $2,832,000 | +2.5% | 290,204 | 0.0% | 0.01% | -12.5% | |
| THLD | THRESHOLD PHARMACEUTICAL INC | $2,124,000 | -16.8% | 536,400 | 0.0% | 0.01% | -28.6% | |
| GMWSB | GENERAL MTRS CO*w exp 07/10/201 | $1,392,000 | +6.6% | 75,000 | 0.0% | 0.00% | 0.0% | |
| PNCWS | PNC FINL SVCS GROUP INC*w exp 12/31/201 | $985,000 | +10.2% | 37,900 | 0.0% | 0.00% | +50.0% | |
| CUB | CUBIC CORP | $625,000 | -12.8% | 14,036 | 0.0% | 0.00% | 0.0% | |
| QTM | QUANTUM CORP | $953,000 | 0.0% | 781,300 | 0.0% | 0.00% | -33.3% | |
| GCVRZ | SANOFIright 12/31/2020 | $307,000 | +61.6% | 614,455 | 0.0% | 0.00% | 0.0% | |
| CYTX | CYTORI THERAPEUTICS INC | $299,000 | -11.3% | 124,911 | 0.0% | 0.00% | 0.0% | |
| TXI | TEXAS INDS INC | $248,000 | +3.3% | 2,680 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 43 | Q3 2023 | 6.0% |
| MICROSOFT CORP | 43 | Q3 2023 | 5.5% |
| AMAZON COM INC | 43 | Q3 2023 | 4.0% |
| BERKSHIRE HATHAWAY INC DEL | 43 | Q3 2023 | 1.3% |
| JPMORGAN CHASE & CO | 43 | Q3 2023 | 1.3% |
| EXXON MOBIL CORP | 43 | Q3 2023 | 1.6% |
| JOHNSON & JOHNSON | 43 | Q3 2023 | 1.2% |
| PROCTER & GAMBLE CO | 43 | Q3 2023 | 1.0% |
| WELLS FARGO CO NEW | 43 | Q3 2023 | 1.6% |
| UNITEDHEALTH GROUP INC | 43 | Q3 2023 | 1.2% |
View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | September 11, 2023 | 3,685,625 | 3.8% |
| Verastem, Inc. | August 31, 2023 | 1,300,000 | 5.2% |
| Molecular Templates, Inc. | July 18, 2023 | 4,391,489 | 5.4% |
| ABEONA THERAPEUTICS INC. | July 06, 2023 | 3,249,994 | 15.3% |
| Praxis Precision Medicines, Inc. | June 30, 2023 | 7,930,638 | 6.2% |
| REATA PHARMACEUTICALS INC | June 26, 2023 | 1,730,841 | 5.2% |
| Provention Bio, Inc. | February 21, 2023 | 5,398,825 | 6.0% |
| ADAMS NATURAL RESOURCES FUND, INC. | February 09, 2023 | 1,308,791 | 5.4% |
| Akili, Inc.Sold out | February 09, 2023 | 0 | 0.0% |
| Ambrx Biopharma Inc. | February 09, 2023 | 7,191,037 | 2.7% |
View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-04-11 |
| SC 13G | 2024-02-26 |
| SC 13G | 2024-02-26 |
| SC 13G | 2024-02-23 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-12 |
| SC 13G/A | 2024-02-07 |
| SC 13G/A | 2024-02-07 |
| SC 13G/A | 2024-02-07 |
View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.